510(k) Report

510(k) · Cleared

Cleared

Synchron Systems 10 NG/ML & 40 NG/ML THC Urine Controls

K971210510(k) TraditionalCleared Apr 17, 199715-day reviewClass I21 CFR 862.3280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Instruments, Inc. · LAS Drug Specific Control Materials

Cleared on Apr 17, 1997 as substantially equivalent to K932113 (Diagnostic Reagents, Inc., 1993) after a 15-day review. Its family tree reaches back 1 generation to 1993.

Decided
Apr 17, 1997
Review
15 days
Class
Class I
Product code
LAS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K932113 (1993). No later device cites it as a predicate yet.

K932113 · Cannabinoid Urine Controls · Diagnostic Reagents, Inc. · 199319901992199419961998
  1. Root · 1 generation backK932113 Cannabinoid Urine ControlsDiagnostic Reagents, Inc. · 1993
  2. This deviceK971210 Synchron Systems 10 NG/ML & 40 NG/ML THC Urine ControlsBeckman Instruments, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K932113Cannabinoid Urine ControlsDiagnostic Reagents, Inc.1993—
0 (this device)K971210Synchron Systems 10 NG/ML & 40 NG/ML THC Urine ControlsBeckman Instruments, Inc.1997—
FIG. 1 — Lineage of K971210, 1993–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K932113Cannabinoid Urine Controls
Summary page 1
…3.2 Classification Names Clinical Toxicology Control Material (21 CFR § 862.3280) Predicate Device(s): A® Cannabinoid Urine Controls, Diagnostic Reagents, Inc. (DRI), K932113 Description: The SYNCHRON® Systems 10 ng/mL and 40ng/mL THC Urine Controls, are ready-to-use, human urine based liquid controls…
Diagnostic Reagents, Inc.1993—

Also cleared against K932113: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K932113.

How does its category compare?

All LAS devices

LAS Drug Specific Control Materials: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LAS

1in 2009

2008: 12009: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LAS

Too few LAS 510(k)s in any year since 2007 to give a median.

Recalls per year · LAS

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LAS

No MAUDE report names LAS since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20091—00
20100—00
20110—00
20120—00
20130—10
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The SYNCHRON Systems 10 ng/mL and 40 ng/mL THC Urine Controls, in conjunction with the SYNCHRON Cannabinoid 20 ng (THC2) Reagent, are intended for use on SYNCHRON Systems for monitoring the quality control of cannabinoid (THC) testing in the clinical laboratory. These controls are designed for use with the family of SYNCHRON Systems which include analyzers such as the SXNCHRON CX4, CX®4CE, CX4 DELTA, CX5, CX5CE, CX5 DELTA, CX7, CX7 DELTA Systems and LX™20 Systems.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971210: Synchron Systems 10 NG/ML & 40 NG/ML THC Urine Controls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K971210

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026